Serum fibroblast growth factor-23 levels in chronic haemodialysis patients

被引：0
|
作者：
Salwa Ibrahim
Laila Rashed
机构：
[1] Cairo University,Department of Medicine
[2] Cairo University,Department of Biochemistry
来源：
International Urology and Nephrology | 2009年 / 41卷
关键词：
Fibroblast growth factor 23; Hemodialysis; Hyperparathyroidism; Hyperphosphataemia; End-stage renal disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：163 / 169
页数：6
相关论文
共 50 条
  • [1] Serum fibroblast growth factor-23 levels in chronic haemodialysis patients
    Ibrahim, Salwa
    Rashed, Laila
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2009, 41 (01) : 163 - 169
  • [2] Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients
    Mizuiri, Sonoo
    Nishizawa, Yoshiko
    Yamashita, Kazuomi
    Ono, Kyoka
    Oda, Maya
    Usui, Kohji
    Shigemoto, Kenichiro
    NEPHROLOGY, 2014, 19 (09) : 568 - 573
  • [3] Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients
    Sugimoto, Himiko
    Ogawa, Tetsuya
    Iwabuchi, Yuko
    Otsuka, Kuniaki
    Nitta, Kosaku
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (01) : 99 - 106
  • [4] Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients
    Nakanishi, S
    Kazama, JJ
    Nii-Kono, T
    Omori, K
    Yamashita, T
    Fukumoto, S
    Gejyo, F
    Shigematsu, T
    Fukagawa, M
    KIDNEY INTERNATIONAL, 2005, 67 (03) : 1171 - 1178
  • [5] Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients
    Himiko Sugimoto
    Tetsuya Ogawa
    Yuko Iwabuchi
    Kuniaki Otsuka
    Kosaku Nitta
    International Urology and Nephrology, 2014, 46 : 99 - 106
  • [6] Serum Fibroblast Growth Factor-23 Levels and Progression of Aortic Arch Calcification in Non-Diabetic Patients on Chronic Hemodialysis
    Tamei, Noriko
    Ogawa, Tetsuya
    Ishida, Hideki
    Ando, Yoshitaka
    Nitta, Kosaku
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011, 18 (03) : 217 - 223
  • [7] Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease
    Siomou, Ekaterini
    Challa, Anna
    Printza, Nikoleta
    Giapros, Vasileios
    Petropoulou, Fotini
    Mitsioni, Andromachi
    Papachristou, Fotios
    Stefanidis, Constantinos J.
    PEDIATRIC NEPHROLOGY, 2011, 26 (07) : 1105 - 1114
  • [8] Regulation of fibroblast growth factor-23 in chronic kidney disease
    Westerberg, Per-Anton
    Linde, Torbjoern
    Wikstroem, Bjoern
    Ljunggren, Oesten
    Stridsberg, Mats
    Larsson, Tobias E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (11) : 3202 - 3207
  • [9] Fibroblast growth factor-23 and Klotho in chronic kidney disease
    Vervloet, Marc G.
    Larsson, Tobias E.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2011, 1 (04) : 130 - 135
  • [10] Fibroblast growth factor-23 as a possible cause of left ventricular hypertrophy and pulmonary hypertension in haemodialysis patients
    El-Adawy, Noussa Mahmoud
    Helmy, Amal Kamal
    Ismail, Tamer Taha
    Tawfik, Abd El Rahman Sayed
    Keryakos, Hesham Kamal Habeeb
    Abu Ela, Mostafa Ahmed El Sayed
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0H) : H2 - H2
12345